Blood Platelet Disorders  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Blood Platelet Disorders
FAST, NCT02611973: Hydroxyurea Versus Aspirin and Hydroxyurea in Essential Thrombocythemia

Recruiting
3
2250
Europe
Aspirin therapy interruption, Usual treatment by aspirin 100 mg/d in the active comparator arm, No interruption of aspirin in the Observational arm, Hydroxyurea treatment (HU)
Assistance Publique - Hôpitaux de Paris
MPN, Essential Thrombocythemia
11/19
11/22

Download Options